Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Belumosudil mesylate (KD025 mesylate) is a compound that selectively inhibits ROCK2, demonstrating IC50 values of 105 nM for ROCK2 and 24 μM for ROCK1. It possesses anti-fibrotic properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 39.00 | |
5 mg | 5 days | $ 77.00 |
Description | Belumosudil mesylate (KD025 mesylate) is a compound that selectively inhibits ROCK2, demonstrating IC50 values of 105 nM for ROCK2 and 24 μM for ROCK1. It possesses anti-fibrotic properties. |
Targets&IC50 | ROCK1:24 μM (IC50), ROCK2:105 nM (IC50) |
In vitro | Belumosudil (SLx-2119; 40 μM) significantly reduces Tsp-1 and CTGF mRNA levels in PASMC. Additionally, microarray analysis reveals that aRNA from HMVEC treated with Belumosudil exhibits a background five times higher than that of other arrays[1]. |
In vivo | Belumosudil (KD-025), administered intraperitoneally at doses of 100, 200, or 300 mg/kg, has been shown to reduce infarct volume in a dose-dependent manner following transient middle cerebral artery occlusion. Its efficacy is consistent across different demographics, including aged, diabetic, or female mice, matching or exceeding that observed in normal adult male subjects[2]. |
Synonyms | SLx-2119mesylate, KD025 mesylate |
Molecular Weight | 548.62 |
Formula | C27H28N6O5S |
CAS No. | 2109704-99-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Belumosudil mesylate 2109704-99-4 KD-025 Mesylate SLx-2119mesylate KD 025 Mesylate KD025 Mesylate KD025 mesylate Belumosudil Mesylate inhibitor inhibit